首页> 美国卫生研究院文献>Journal of Virology >Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats but does not confer protection.
【2h】

Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats but does not confer protection.

机译:用猫免疫缺陷病毒多表位肽进行疫苗接种可在猫中诱导细胞介导的体液免疫反应但不能起到保护作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cats were immunized with a 46-residue multiepitopic synthetic peptide of feline immunodeficiency virus (FIV) comprising immunodominant epitopes present in the third variable domain of the envelope glycoprotein, transmembrane glycoprotein (TM), and p24 Gag core protein, using Quil A as an adjuvant. All vaccinated cats developed a humoral response which recognized the synthetic peptide immunogen and the intact viral core and envelope proteins. A FIV Gag- and Env-specific effector cytotoxic T-lymphocyte response was also detected in the peripheral blood of vaccinated cats, which peaked at week 30. This response appeared to be major histocompatibility complex restricted. Epitope mapping studies revealed that both the cellular and humoral immune responses were directed principally to a peptide within the TM glycoprotein, CNQNQFFCK. However, vaccination did not confer protection when cats were challenged with the Petaluma isolate of FIV at week 35.
机译:使用Quil A作为佐剂,用46个残基的猫免疫缺陷病毒(FIV)多表位合成肽免疫猫,该肽包含存在于包膜糖蛋白,跨膜糖蛋白(TM)和p24 Gag核心蛋白第三可变域中的免疫优势表位。所有接种疫苗的猫都产生了体液反应,该反应识别了合成的肽免疫原以及完整的病毒核心和包膜蛋白。在疫苗接种猫的外周血中也检测到了FIV Gag和Env特异的效应细胞毒性T淋巴细胞反应,该反应在第30周达到高峰。这种反应似乎是主要的组织相容性复合物受限制。表位作图研究表明,细胞和体液免疫反应均主要针对TM糖蛋白CNQNQFFCK中的一种肽。但是,在第35周时,用FIV的Petaluma分离株攻击猫时,接种疫苗并没有提供保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号